ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Indianapolis, IN, USA:

Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer

This open-label, non-randomized Phase II trial is designed to assess the safety and tolerability of GT103 in combination with pembrolizumab ...

Active, not recruiting
Recurrent Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
Drug: GT103
Drug: Pembrolizumab

Phase 2

Jeffrey Clarke

Indianapolis, Indiana, United States and 5 other locations

Locations recently updated

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell...

Enrolling
Non Small Cell Lung Cancer
Drug: Docetaxel
Biological: Telisotuzumab Vedotin

Phase 3

AbbVie
AbbVie

Indianapolis, Indiana, United States and 295 other locations

study population comprises adults with either advanced/metastatic non-small cell lung cancer (NSCLC) wit...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Advanced Lung Carcinoma
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Indianapolis, Indiana, United States and 43 other locations

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...

Active, not recruiting
Advanced Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Drug: Docetaxel
Drug: MRTX849

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Indianapolis, Indiana, United States and 347 other locations

in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...

Active, not recruiting
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
Drug: platinum-based chemotherapy
Drug: furmonertinib 240 mg oral, daily

Phase 3

ArriVent BioPharma
ArriVent BioPharma

Indianapolis, Indiana, United States and 207 other locations

The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment....

Begins enrollment this month
Immunotherapy
Stage IV NSCLC
Dietary Supplement: FMD
Combination Product: Regular Diet Plus FMD
VA Office of Research and Development
VA Office of Research and Development

Indianapolis, Indiana, United States and 3 other locations

The purpose of eVOLVE-Lung02 is to test the effectiveness (efficacy) and measure the safety of volrustomig in combination with chemotherapy ...

Enrolling
Metastatic Non-small Cell Lung Cancer
Drug: Pembrolizumab
Drug: Pemetrexed

Phase 3

AstraZeneca
AstraZeneca

Indianapolis, Indiana, United States and 288 other locations

observation following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) wit...

Enrolling
NSCLC, Stage I
Drug: Pembrolizumab

Phase 2

Greg Durm, MD

Indianapolis, Indiana, United States and 12 other locations

This phase II Expanded Lung-MAP treatment trial tests tepotinib with or without ramucirumab for the treatment of patients with advanced non...

Enrolling
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Procedure: Magnetic Resonance Imaging
Biological: Ramucirumab

Phase 2

SWOG Cancer Research Network
SWOG Cancer Research Network

Indianapolis, Indiana, United States and 239 other locations

Locations recently updated

with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung cancer (NSCLC)....

Enrolling
KRAS G12C Lung Cancer
Non-Small Cell Lung Cancer
Drug: Sotorasib
Drug: Divarasib

Phase 3

Roche
Roche

Muncie, Indiana, United States and 244 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems